TrialIntensive care medicine2022

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia.

Anders Granholm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.